Original Article

You have full text access to this OnlineOpen article

Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma

  1. Johan S. Rietman M.D.1,2,†,*,
  2. Pieter U. Dijkstra P.T., M.T., Ph.D.1,2,
  3. Jan H. B. Geertzen M.D., Ph.D.1,2,
  4. Peter Baas M.D., Ph.D.3,
  5. Jaap de Vries M.D., Ph.D.4,
  6. Wil Dolsma M.D., Ph.D.5,
  7. Johan W. Groothoff M.Sc., Ph.D.2,
  8. Willem H. Eisma M.D.1,
  9. Harald J. Hoekstra M.D., Ph.D.4

Article first published online: 20 JUN 2003

DOI: 10.1002/cncr.11545

Issue

Cancer

Cancer

Volume 98, Issue 4, pages 690–696, 15 August 2003

Additional Information

How to Cite

Rietman, J. S., Dijkstra, P. U., Geertzen, J. H. B., Baas, P., de Vries, J., Dolsma, W., Groothoff, J. W., Eisma, W. H. and Hoekstra, H. J. (2003), Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma. Cancer, 98: 690–696. doi: 10.1002/cncr.11545

Author Information

  1. 1

    Department of Rehabilitation, Groningen University Hospital, Groningen, The Netherlands

  2. 2

    Northern Centre for Health Care Research, University Groningen, Groningen, The Netherlands

  3. 3

    Department of Surgery, Martini Hospital, Groningen, The Netherlands

  4. 4

    Department of Surgical Oncology, Groningen University Hospital, Groningen, The Netherlands

  5. 5

    Department of Radiotherapy, Groningen University Hospital, Groningen, The Netherlands

  1. †

    Fax: (011) 3150 3611708

*Department of Rehabilitation Medicine, Groningen University Hospital, P.O. Box 30001, NL-9700 RB Groningen, The Netherlands

Publication History

  1. Issue published online: 1 AUG 2003
  2. Article first published online: 20 JUN 2003
  3. Manuscript Accepted: 29 APR 2003
  4. Manuscript Revised: 15 APR 2003
  5. Manuscript Received: 19 FEB 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (86K)

REFERENCES

  • 1
    Visser O, Coebergh JWW, Schouten LJ, van Dijck JAAM. Incidence of cancer in the Netherlands 1997. Ninth report of the Netherlands Cancer Registry. Utrecht: Netherlands Cancer Registry, 2001.
  • 2
    Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics 2001. CA Cancer J Clin. 2001; 51: 15–36.
    Direct Link:
  • 3
    Moffat FL, Senofsky GM, Davis K, et al. Axillary node dissection for early breast cancer: some is good, but all is better. J Surg Oncol. 1992; 51: 8–13.
    Direct Link:
  • 4
    Donegan WL. Prognostic factors: stage and receptor status in breast cancer. Cancer. 1992; 70: 1755–1764.
    Direct Link:
  • 5
    Fisher B, Bauer M, Wickerham DL, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer. 1983; 52: 1551–1557.
    Direct Link:
  • 6
    Carter CL, Allen C, Henson DE. Relation of tumour size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989; 63: 181–187.
    Direct Link:
  • 7
    Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer: a review. Cancer. 1995; 76: 1491–1512.
    Direct Link:
  • 8
    Thomson AM, Air M, Jack WJL, Kerr GR, Rodger A, Chetty U. Arm morbidity after breast conservation and axillary therapy. Breast. 1995; 4: 273–276.
  • 9
    Liljegren G, Holmberg L. Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer Stage I. Results from a randomised trial. Eur J Cancer. 1997; 33: 193–199.
  • 10
    Pezner RD, Patterson MP, Hill RL, et al. Arm lymphoedema in patients treated conservatively for breast cancer: relationship to patients age and axillary node dissection techniques. Int J Radiat Oncol Biol Phys. 1986; 12: 2079–2083.
  • 11
    Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT. Assessment of morbidity from complete axillary dissection. Br J Cancer. 1992; 66: 136–138.
  • 12
    Warmuth MA, Bowen G, Pronitz LR, et al. Complications of axillary lymph node dissection for carcinoma of the breast. Cancer. 1998; 83: 1362–1368.
    Direct Link:
  • 13
    Kuehn T, Klauss W, Darsow M, et al. Long-term morbidity following axillary dissection in breast cancer patients—clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat. 2000; 64: 275–286.
  • 14
    Rietman JS, Dijkstra PU, Hoekstra HJ, et al. Late morbidity after treatment of breast cancer in relation to daily activities and quality of life; a systematic review. Eur J Surg Oncol. 2003; 29: 229–238.
  • 15
    Swedborg I, Borg G, Sarnelid M. Somatic sensation and discomfort in the arm of post-mastectomy patients. Scand J Rehabil Med. 1981; 13: 23–29.
  • 16
    Tobin MB, Lacey HJ, Meyer L, Mortimer PS. The psychological morbidity of breast cancer-related arm swelling. Cancer. 1993; 72: 3248–3253.
    Direct Link:
  • 17
    Maunsell E, Brisson J, Deschènes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg. 1992; 36: 315–320.
  • 18
    Hack TF, Cohen L, Katz J, Robson LS, Goss P. Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol. 1999; 17: 143–149.
  • 19
    Ververs JMMA, Roumen RMH, Vingerhoets AJJM, et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer. 2001; 37: 991–999.
  • 20
    Poole K, Fallowfield LJ. The psychological impact of post-operative arm morbidity following axillary surgery for breast cancer: a critical review. Breast. 2002; 11: 81–87.
  • 21
    Kwan W, Jackson J, Weir LM, Dingee C, McGregor G, Olivotto IA. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol. 2002; 20: 4242–4248.
  • 22
    Tasmuth T, von Smitten K, Kalso E. Pain and other symptoms during the first year after radical and conservative surgery for breast cancer. Br J Cancer. 1996; 74: 2024–2031.
  • 23
    Sakorafas GH, Tsiotou AG, Balsiger BM. Axillary lymph node dissection in breast cancer: current status and controversies, alternative strategies and future perspectives. Acta Oncol. 2000; 4: 455–466.
  • 24
    Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995; 222: 394–399.
  • 25
    Statman RC, Jones RC, Cabot MC, et al. Sentinel lymphadenectomy. A technique to eliminate axillary dissection in node-negative breast cancer. [abstract] Proc Am Soc Clin Oncol. 1996; 15: 167a.
  • 26
    Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer. 2000; 88: 608–614.
    Direct Link:
  • 27
    Schrenk P, Hatzl-Griesenhofer M, Shamiyeh A, Waynad W. Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol. 2001; 77: 165–170.
    Direct Link:
  • 28
    Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet. 1997; 349: 1864–1867.
  • 29
    Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer. 2001; 92: 748–752.
    Direct Link:
  • 30
    Haid A, Köberle-Wührer R, Knauer M, et al. Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat. 2002; 73: 31–36.
  • 31
    Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg. 2002; 183: 23–27.
  • 32
    Baron RH, Fey JV, Raboy S, et al. Eighteen sensations after breast cancer surgery: a comparison of sentinel lymph node biopsy and axillary lymph node dissection. Oncol Nurs Forum. 2002; 29: 652–659.
  • 33
    Temple LKF, Baron R, Cody HS, et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol. 2002; 9: 654–662.
  • 34
    Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol. 2002; 9: 745–753.
  • 35
    Haid A, Kuehn P, Konstantiniuk R, et al. Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol. 2002; 28: 705–710.
  • 36
    SobinLH, WittekindC, editors. TNM classification of malignant tumours 5th edition, New York: John Wiley & Sons, 1997.
  • 37
    Rutgers EJ, Jansen L, Nieweg OE, de Vries J, Schraffordt Koops H, Kroon BB. Technique of sentinel node biopsy in breast cancer. Eur J Surg Oncol. 1998; 24: 316–319.
  • 38
    Hladiuk M, Huchcroft S, Temple W, Schnurr BE. Arm function after axillary dissection for breast cancer: a pilot study to provide parameter estimates. J Surg Oncol. 1992; 50: 47–52.
    Direct Link:
  • 39
    Jensen MP, Karoly P, Braver S. The measurement of clinical pain intensity: a comparison of six methods. Pain. 1986; 27: 117–126.
  • 40
    Gerber L, Lampert M, Wood C, et al. Comparison of pain, motion and edema after modified radical mastectomy vs. local excision with axillary dissection and radiation. Breast Cancer Res Treat. 1992; 21: 139–145.
  • 41
    Green S, Buchbinder R, Forbes A, Bellamy N. A standardized protocol for measurement of range of movement of the shoulder using the Plurimeter-V inclinometer and assessment of its intrarater and interrater reliability. Arthritis Care Res. 1998; 11: 43–52.
    Direct Link:
  • 42
    Van der Ploeg RJ. Hand-held dynamometry [thesis]. Groningen: University of Groningen, 1992.
  • 43
    Van der Ploeg RJ, Fidler V, Oosterhuis HJ. Hand-held myometry: reference values. J Neurol Neurosurg Psychiatry. 1991; 54: 244–247.
  • 44
    Balogun JA, Powell R, Trullender B, Olson S, Balogun AO. Intra- and inter-tester reliability of the NicholasR hand-held dynamometer during evaluation of upper extremity isometric muscle strength. Eur J Phys Med Rehabil. 1998; 8: 48–53.
  • 45
    Mathiowetz V, Weber K, Volland G, Kashman N. Reliability and validity of grip and pinch strength evaluations. J Hand Surg [Am]. 1984; 9: 222–226.
  • 46
    Van der Heijden GJ. Shoulder disorder treatment: efficacy of ultrasound therapy and electrotherapy [thesis]. Maastricht: University of Maastricht, 1996.
  • 47
    Van der Heijden GJ, Leffers P, Bouter LM. Shoulder disability questionnaire design and responsiveness of a functional status measure. J Clin Epidemiol. 2000; 53: 29–38.
  • 48
    Kempen GI, Miedema I, Ormel J, Molenaar W. The assessment of disability with the Groningen Activity Restriction Scale. Conceptual framework and psychometric properties. Soc Sci Med. 1996; 43: 1601–1610.
  • 49
    Suurmeijer TP, Doeglas DM, Moum T, et al. The Groningen Activity Restriction Scale for measuring disability: its utility in international comparisons. Am J Public Health. 1994; 84: 170–173.
View Full Article (HTML) Get PDF (86K)